Implementation of a drug-use and disease-state management program

• Published in: American journal of health-system pharmacy 2000-12, Vol.57 (24), p.S23-S29
• Main Authors: SKLEDAR, Susan J, HESS, Mary M
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Disease Management; Drug Utilization Review; Health and social institutions; Hospitals, Teaching; Humans; Medical sciences; Organization; Organizational Case Studies; Pennsylvania; Pharmacy Service, Hospital - economics; Pharmacy Service, Hospital - organization & administration; Pharmacy Service, Hospital - standards; Practice Guidelines as Topic; Program Development; Public health. Hygiene; Public health. Hygiene-occupational medicine; Safety Management - economics; Treatment Outcome
• ISSN: 1079-2082; 1535-2900
• DOI: 10.1093/ajhp/57.suppl_4.S23

A drug-use and disease-state management (DUDSM) program was instituted in 1996 at a teaching hospital associated with a large nonprofit health care system. The program's goals are to optimize pharmacotherapeutic regimens, evaluate health outcomes of identified disease states, and evaluate the economic impact of pharmacotherapeutic options for given disease states by developing practice guidelines. Through a re-engineering process, resources within the pharmacy department were identified that could be devoted to the DUDSM program, including the use of clinical pharmacy specialists, promotion of staff pharmacists into the DUDSM program, a pharmacy technician, and information systems support. A strength of the program is its systematic approach for developing and implementing new initiatives, as well as monitoring compliance with all initiatives on an ongoing basis. The initiative-design process incorporates continuous quality improvement principles, outcome design and evaluation, competency assessment for all pharmacists, multidisciplinary collaboration, and sophisticated information systems. Seventy-five initiatives have been implemented, ranging from simple dose-optimization strategies for specific drugs to complicated practice guidelines for managing specific disease states. Improved patient outcomes have been documented, including reduced length of stay, postsurgical wound infection, adverse drug reactions, and medication errors. Documented cost savings exceeded $4 million annually for fiscal years 1996-97 through 1999-2000. Overall compliance with DUDSM initiatives exceeds 80%, and physician service profiling has been initiated to monitor variant prescribing. The DUDSM program has successfully integrated practice guidelines into therapeutic decision-making, resulting in improved patient-care outcomes and cost savings.